Lifevantage (NASDAQ:LFVN) Announces Quarterly Earnings Results

Lifevantage (NASDAQ:LFVN) issued its earnings results on Monday. The company reported $0.05 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.06 by ($0.01), FiscalAI reports. The firm had revenue of $37.12 million during the quarter, compared to the consensus estimate of $40.49 million. Lifevantage had a return on equity of 21.56% and a net margin of 2.78%.

Lifevantage Stock Performance

Shares of LFVN traded up $0.07 during mid-day trading on Monday, hitting $5.29. 30,822 shares of the company traded hands, compared to its average volume of 216,061. The stock has a market cap of $66.60 million, a price-to-earnings ratio of 13.22 and a beta of 0.71. The stock has a 50-day moving average price of $6.06 and a two-hundred day moving average price of $5.88. Lifevantage has a 1 year low of $3.90 and a 1 year high of $11.71.

Lifevantage Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 15th. Stockholders of record on Tuesday, September 1st were issued a dividend of $0.05 per share. This represents a $0.20 annualized dividend and a dividend yield of 3.8%. The ex-dividend date of this dividend was Tuesday, September 1st. Lifevantage’s payout ratio is presently 50.00%.

Analyst Upgrades and Downgrades

LFVN has been the subject of several analyst reports. Zacks Research downgraded shares of Lifevantage from a “hold” rating to a “strong sell” rating in a research report on Friday, October 16th. Lake Street Capital boosted their price objective on shares of Lifevantage from $5.00 to $6.00 and gave the stock a “hold” rating in a report on Friday, August 28th. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Lifevantage in a research report on Friday, August 21st. Two equities research analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company currently has an average rating of “Reduce” and an average target price of $5.50.

Insider Transactions at Lifevantage

In other Lifevantage news, insider Kristen Cunningham sold 8,901 shares of Lifevantage stock in a transaction that occurred on Monday, September 14th. The shares were sold at an average price of $6.18, for a total value of $55,008.18. Following the completion of the sale, the insider owned 120,162 shares of the company’s stock, valued at approximately $742,601.16. The trade was a 6.90% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 13.58% of the company’s stock.

Lifevantage Company Profile

LifeVantage Corporation is a health and wellness company that develops, markets and distributes dietary supplements and personal-care products. Its product portfolio is designed to support areas such as cellular health, antioxidant defenses, energy, nutrition and skin care.

The company’s principal brands have included Protandim, a line of dietary supplements; TrueScience, a skin-care and wellness brand; and Petandim, products formulated for pets. LifeVantage primarily uses a direct-selling business model, distributing its products through independent sales representatives and online channels.

Founded in 2003 and headquartered in Lehi, Utah, LifeVantage serves customers in the United States and selected international markets.